Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines
Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines
复制标题
启动子甲基化、突变和基因组缺失与多种癌细胞系中 NDRG2 表达水平降低有关。
DOI:
10.1016/j.bbrc.2007.04.089
复制
发表时间:
2007-06-22
影响因子:
3.1
通讯作者:
Yao, Libo
中科院分区:
文献类型:
--
作者:
Liu, Na;Wang, Lifeng;Yao, Libo
Human NDRG2 (N-Myc downstream regulated gene 2) was identified as a candidate tumor suppressor gene due to its low expression in human glioma and other cancer tissues. However, the mechanisms that lead to inactivation of the NDRG2 gene remain unknown. In the present study, semi-quantitative RT-PCR and Western blot analysis were used to confirm that NDRG2 mRNA and protein levels are decreased in several cancer cell lines. We found heterozygous deletion of NDRG2 in MCF-7 cells, and showed that mutation (at -13 bp (C > T)) and methylation of the NDRG2 promoter occurred in several cancer cell lines. Furthermore, mutation (-13 bp (C > T)) of the NDRG2 core promoter significantly reduced NDRG2 activity. Finally, we showed that NDRG2 expression was decreased in several breast cancer tissues. Unexpectedly, changes in the NDRG2 gene were not observed. Here, we describe for the first time, the mechanisms involved in NDRG2 gene down-regulation. (c) 2007 Elsevier Inc. All rights reserved.